Amendment No. 1 to Capital on Demand™ Sales Agreement Sample Contracts

Lexaria Bioscience Corp. Kelowna, BC, Canada V1X 2P7 Re: Amendment No. 1 to Capital on Demand™ Sales Agreement Ladies and Gentlemen:

Amendment No. 1 to Capital on Demand™ Sales Agreement • February 5th, 2025 • Lexaria Bioscience Corp. • Pharmaceutical preparations

• Contract Type
  Amendment No. 1 to Capital on Demand™ Sales Agreement
• Filed
  February 5th, 2025
• Company
  Lexaria Bioscience Corp.
• Industry
  Pharmaceutical preparations

Reference is made to the Capital on Demand™ Sales Agreement, dated as of August 21, 2024 (the “Sales Agreement”), between Lexaria Bioscience Corp (the “Company”) and JonesTrading Institutional Services LLC (“Jones”). This Amendment No. 1 to the Sales Agreement (this “Amendment”) constitutes an agreement between the Company and Jones to amend the Sales Agreement as set forth herein. Defined terms that are used but not defined herein shall have the meanings ascribed to such terms in the Sales Agreement.